AQR Arbitrage’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

AQR Arbitrage’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-294,525	Closed	-$16.5K	–	844
2023 Q3	$16.5K	Hold	294,525	–	–	﹤0.01%	553
2023 Q2	$43.4K	Sell	294,525 -2,514	-0.8%	-$260	﹤0.01%	535
2023 Q1	$28.2K	Sell	297,039 -14,938	-5%	-$1.2K	﹤0.01%	687
2022 Q4	$31.2K	Hold	311,977	–	–	﹤0.01%	765
2022 Q3	$25K	Hold	311,977	–	–	﹤0.01%	960
2022 Q2	$44K	Hold	311,977	–	–	﹤0.01%	919
2022 Q1	$69K	Buy	+311,977	New	+$81K	﹤0.01%	844

AQR Arbitrage's BIOSW Position: Q4 2023 in Review

AQR Arbitrage sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 294,525 shares — an estimated $16.5K sold.

AQR Arbitrage first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $69K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

AQR Arbitrage reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
AQR Arbitrage sold 294,525 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $16.5K.
AQR Arbitrage first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
AQR Arbitrage's BioPlus Acquisition Corp. Warrants position peaked at $69K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on AQR Arbitrage's 13F filing for Q4 2023, filed 14 Feb 2024.